BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 32020359)

  • 1. Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction.
    Lechner S; Yee M; Limketkai BN; Pham EA
    Dig Dis Sci; 2020 Mar; 65(3):897-905. PubMed ID: 32020359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation.
    DuPont HL; Jiang ZD; DuPont AW; Utay NS
    Dig Dis Sci; 2020 Mar; 65(3):741-756. PubMed ID: 32008133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).
    Nobili V; Mosca A; Alterio T; Cardile S; Putignani L
    Adv Exp Med Biol; 2019; 1125():85-100. PubMed ID: 30578461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation in cancer management: Current status and perspectives.
    Chen D; Wu J; Jin D; Wang B; Cao H
    Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond
    Bakker GJ; Nieuwdorp M
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the gut-liver axis in liver disease.
    Wiest R; Albillos A; Trauner M; Bajaj JS; Jalan R
    J Hepatol; 2017 Nov; 67(5):1084-1103. PubMed ID: 28526488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Application and Potential of Fecal Microbiota Transplantation.
    Ooijevaar RE; Terveer EM; Verspaget HW; Kuijper EJ; Keller JJ
    Annu Rev Med; 2019 Jan; 70():335-351. PubMed ID: 30403550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intestinal bacteria involved in nutritional liver disease killed by phagotherapy: a new therapeutic target].
    Ciocan D; Cassard AM
    Med Sci (Paris); 2020 Apr; 36(4):310-312. PubMed ID: 32356701
    [No Abstract]   [Full Text] [Related]  

  • 10. The Super-Donor Phenomenon in Fecal Microbiota Transplantation.
    Wilson BC; Vatanen T; Cutfield WS; O'Sullivan JM
    Front Cell Infect Microbiol; 2019; 9():2. PubMed ID: 30719428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation: past, present and future perspectives.
    Bibbò S; Ianiro G; Gasbarrini A; Cammarota G
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):420-430. PubMed ID: 28927251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies to modulate gut microbiota: Past, present and future.
    Gupta A; Saha S; Khanna S
    World J Gastroenterol; 2020 Feb; 26(8):777-788. PubMed ID: 32148376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor Considerations in Fecal Microbiota Transplantation.
    Barnes D; Park KT
    Curr Gastroenterol Rep; 2017 Mar; 19(3):10. PubMed ID: 28289858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease.
    Hartmann P; Schnabl B
    Semin Liver Dis; 2021 Jan; 41(1):87-102. PubMed ID: 33957682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
    Kump P; Högenauer C
    Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans.
    Staley C; Khoruts A; Sadowsky MJ
    Arch Med Res; 2017 Nov; 48(8):766-773. PubMed ID: 29183720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease.
    Vaughn BP; Rank KM; Khoruts A
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):353-361. PubMed ID: 30055267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Microbiome: What Will the Future Hold?
    Monsour HP; Quigley EM
    Semin Liver Dis; 2016 Sep; 36(4):354-359. PubMed ID: 27997976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Practical Method for Preparation of Fecal Microbiota Transplantation.
    Perez E; Lee CH; Petrof EO
    Methods Mol Biol; 2016; 1476():259-67. PubMed ID: 27507347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.